Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (179K) Freely available
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Giddings, M. C.
Right arrow Articles by Matveeva, O. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giddings, M. C.
Right arrow Articles by Matveeva, O. V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2002, Vol. 30, No. 19 4295-4304
© 2002 Oxford University Press

Artificial neural network prediction of antisense oligodeoxynucleotide activity

Michael C. Giddings*, Atul A. Shah, Sue Freier1, John F. Atkins, Raymond F. Gesteland and Olga V. Matveeva

Department of Human Genetics, University of Utah, SLC, UT 84112, USA and 1 Isis Pharmaceuticals, Carlsbad, CA 92008, USA

*To whom correspondence should be addressed at present address: Department of Microbiology and Immunology, CB 7290, 804 Mary Ellen Jones Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7290, USA. Tel: +1 919 843 3513; Fax: +1 919 962 8103; Email: giddings{at}unc.edu
Present address:
Atul A. Shah, Department of Microbiology and Immunology, CB 7290, 804 Mary Ellen Jones Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7290, USA

An mRNA transcript contains many potential antisense oligodeoxynucleotide target sites. Identifi cation of the most efficacious targets remains an important and challenging problem. Building on separate work that revealed a strong correlation between the inclusion of short sequence motifs and the activity level of an oligo, we have developed a predictive artificial neural network system for mapping tetranucleotide motif content to antisense oligo activity. Trained for high-specificity prediction, the system has been cross-validated against a database of 348 oligos from the literature and a larger proprietary database of 908 oligos. In cross- validation tests the system identified effective oligos (i.e. oligos capable of reducing target mRNA expression to <25% that of the control) with 53% accuracy, in contrast to the <10% success rates commonly reported for trial-and-error oligo selection, suggesting a possible 5-fold reduction in the in vivo screening required to find an active oligo. We have implemented a web interface to a trained neural network. Given an RNA transcript as input, the system identifies the most likely oligo targets and provides estimates of the probabilities that oligos targeted against these sites will be effective.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
X. Bo, S. Lou, D. Sun, J. Yang, and S. Wang
AOBase: a database for antisense oligonucleotides selection and design
Nucleic Acids Res., January 1, 2006; 34(suppl_1): D664 - D667.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. Husken, F. Asselbergs, B. Kinzel, F. Natt, J. Weiler, P. Martin, R. Haner, and J. Hall
mRNA fusion constructs serve in a general cell-based assay to profile oligonucleotide activity
Nucleic Acids Res., September 1, 2003; 31(17): e102 - e102.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
P. Bengert and T. Dandekar
A software tool-box for analysis of regulatory RNA elements
Nucleic Acids Res., July 1, 2003; 31(13): 3441 - 3445.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.